Abstract:BACKGROUND: Understanding the molecular basis underlying metastasis of non-small cell lung cancer (NSCLC) may provide a new therapeutic modality for the treatment of NSCLC. However, the mechanisms by which tumor-associated macrophages (TAMs) affect NSCLC metastasis remain undefined. In this study, we aimed to discover a novel regulatory pathway involved in NSCLC metastasis.METHODS: Cell Counting Kit-8 (CCK-8), Transwell, western blot assays were used to assess cell viability, migration, invasion and epithelial-mesenchymal transition (EMT). Exosomes from macrophages medium were characterized, and in vitro cell coculture was further conducted to investigate M2 derived exosomes mediated crosstalk between TAMs and tumor cells. Besides, miRNA microarray was used to analyze miRNA expression profiles of M0 and M2 derived exosomes. Luciferase reporter assay was used to verify the potential binding between miRNA and mRNA. Moreover, 6-week-old male BALB/c nude mice were performed to establish transplantation tumor model using tail vein injection. Hematoxylin & eosin staining was used to detect the metastasis of tumor tissues.RESULTS: We found that M2 TAMs were the main TAMs in metastatic tissues of NSCLC patients and exosomes derived from M2 TAMs were able to promote cell viability, cell migration, cell invasion and EMT in NSCLC. We demonstrated that miR-155 and miR-196a-5p were abundant in M2 TAMs and exosomes secreted by M2 TAMs. Functional experiments demonstrated that the deletion of miR-155 and miR-196a-5p in M2 TAMs significantly prevented NSCLC metastasis <i>in vitro</i> and <i>in vivo</i>. To clarify the mechanism governing miR-155 and miR-196a-5p from M2 TAMs, we carried out bioinformatics analysis to predict potential target genes. Mechanistically, miR-155 and miR-196a-5p directly bound to the 3'-UTR of Ras association domain family member 4 (RASSF4), and negatively regulating RASSF4 expression. At last, rescue assays demonstrated that miR-155 and miR-196a-5p exerted its performance by RASSF4.CONCLUSIONS: Overall, we revealed a new regulatory pathway that was M2 TAMs secreted exosomal miR-155 and miR-196a-5p to promote NSCLC metastasis. This dynamic and reciprocal cross-talk between NSCLC and macrophages innovatively provided a potential opportunity for diagnosis and treatment of NSCLC.

CCL2 promotes metastasis and epithelial–mesenchymal transition of non‐small cell lung cancer via PI3K/Akt/mTOR and autophagy pathways

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

CCL2 Promotes EGFR-TKIs Resistance in Non-Small Cell Lung Cancer Via the AKT-EMT Pathway

Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells

Ccl2-Ccr2 Axis Promotes Metastasis of Nasopharyngeal Carcinoma by Activating Erk1/2-Mmp2/9 Pathway

Production of CCL20 from Lung Cancer Cells Induces the Cell Migration and Proliferation Through PI3K Pathway.

CXCL5 Regulation of Proliferation and Migration in Human Non-Small Cell Lung Cancer Cells

Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.

Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells

CCL2/CCR2 signaling in cancer pathogenesis

High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.

Cc Chemokine Ligand 18(ccl18) Promotes Migration and Invasion of Lung Cancer Cells by Binding to Nir1 Through Nir1-Elmo1/Doc180 Signaling Pathway

CCL5 promotes the epithelial-mesenchymal transition of circulating tumor cells in renal cancer

CCL25 Promotes the Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating VEGF and MMPs in a CCR9-dependent Manner.

CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells

Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer

Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells Through the CCR7–CCL21 Axis Modulated by TNF-α

circMET promotes NSCLC cell proliferation, metastasis, and immune evasion by regulating the miR-145-5p/CXCL3 axis.

CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer

CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.

CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer